domingo, 28 de mayo de 2023

Global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance - eBioMedicine

Global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance - eBioMedicine

No hay comentarios:

Publicar un comentario